Suven Pharmaceuticals Limited

    Suven Pharmaceuticals Limited

    BBSE:SUVENPHAR
    - -
    INR
    - -
    - -
    111.40P/E
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    2025 Y
    TTM
    Revenue per Share
    14.52
    32.1
    39.1
    51.34
    52.29
    41.31
    47.58
    47.13
    Basic EPS, GAAP
    4.29
    12.45
    14.23
    17.83
    16.16
    11.8
    10.52
    10.41
    Free Cash Flow per Basic Share
    -0.25
    11.94
    10.67
    10.01
    6.73
    13.08
    5.26
    - -
    Dividend per Share
    0.9
    3.01
    1
    4
    8
    - -
    - -
    - -
    Book Value per Share
    15.86
    24.68
    37.79
    51
    58.56
    70.36
    1.01
    1
    Tangible Book Value per Share
    23.08
    33.07
    46.28
    59.9
    65.72
    78.15
    44.57
    44.14
    Basic Weighted Avg Shares
    255
    255
    255
    255
    255
    254
    252
    254
    Sales/Revenue/Turnover
    3,696
    8,173
    9,955
    13,070
    13,311
    10,514
    11,976
    11,976
    Operating Margin (%)
    44.1
    44.22
    41.32
    41.56
    39.54
    33.41
    24.86
    24.86
    Depreciation Expense
    115
    237
    312
    383
    465
    546
    775
    775
    Net Income, GAAP
    1,093
    3,170
    3,623
    4,538
    4,113
    3,003
    2,648
    2,645
    Effective Tax Rate (%)
    30.78
    21.63
    22.52
    32.02
    26.52
    25.98
    23.01
    23.01
    Profit Margin (%)
    29.57
    38.79
    36.4
    34.72
    30.9
    28.56
    22.11
    22.09
    Working Capital
    2,321
    1,913
    3,450
    9,176
    8,523
    11,563
    5,234
    5,234
    LT Debt
    - -
    918
    363
    289
    53
    212
    1,757
    1,757
    Total Equity
    5,903
    8,448
    11,808
    15,272
    17,352
    20,507
    18,406
    18,406
    Return on Invested Capital (%)
    - -
    33.14
    27.01
    25.02
    22.52
    13.26
    10.82
    10.82
    Return on Capital (%)
    - -
    51.14
    38.49
    36.64
    28.46
    17.9
    23.81
    23.75
    Return on Common Equity (%)
    - -
    61.44
    45.57
    40.16
    29.5
    18.3
    29.16
    29.13

    Capital Structure

    INR

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'25
    ST Debt
    88
    - -
    1,033
    LT Borrowings
    71
    - -
    62
    LT Finance Leases
    235
    - -
    1,695
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    255
    - -
    255
    Market Capitalization
    298,090
    288,661
    294,709

    Working Capital

    INR

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'25
    Total Current Assets
    11,677
    - -
    8,886
    Cash, Cash Equivalents & STI
    6,730
    - -
    2,904
    Accounts Receivable, Net
    1,840
    - -
    2,844
    Inventories
    2,155
    - -
    1,666
    Total Current Liabilities
    2,381
    - -
    3,652
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    88
    - -
    1,033
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    INR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    18.13%
    -10.24%
    Free Cash Flow
    - -
    -3.09%
    -60.21%
    Net Income, GAAP
    - -
    -1.73%
    -11.83%
    Sales/Revenue/Turnover
    - -
    9.57%
    13.91%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    INR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    3,388
    2,784
    3,538
    3,601
    13,311
    2024
    3,476
    2,311
    2,198
    2,374
    10,514
    2025
    2,307
    2,577
    3,072
    4,020
    11,976

    Quarterly Earnings Per Share

    INR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    4.22
    2.83
    4.23
    - -
    16.16
    2024
    4.74
    3.12
    1.84
    - -
    11.8
    2025
    2.39
    3.23
    3.26
    - -
    10.52

    Quarterly Dividends Per Share

    INR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    8
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business